{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T04:03:56Z","timestamp":1746763436410,"version":"3.40.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013281","name":"Joint Programming Initiative on Antimicrobial Resistance","doi-asserted-by":"publisher","award":["JPIAMR2017-045"],"award-info":[{"award-number":["JPIAMR2017-045"]}],"id":[{"id":"10.13039\/100013281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Antimicrobial lead time (ALT) is the time from antimicrobial order to administration, an understudied parameter. This study aims to determine feasibility of retrieving ALT, differences in ALT for different infectious diseases and the association of ALT with length of stay (LoS) in order to establish the value of this parameter as potential new process or quality indicator (QI).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In a retrospective study in a tertiary care hospital in the Netherlands, adult hospitalized patients treated for an infection were included over a 20-month period. ALT was calculated with data from the electronic health record system with computerized provider order entry.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Thousand patients (56.1% men, median age 61 years) were included. The median ALT was 1.05\u00a0h and significantly shorter in septic patients (<jats:italic>n<\/jats:italic>\u2009=\u200965) than in patients with other infections (<jats:italic>n<\/jats:italic>\u2009=\u2009935; 0.27\u00a0h, interquartile range (IQR) 0.07\u20130.67 vs. 1.18\u00a0h, IQR 0.37\u20133.15; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). If blood cultures were obtained median ALT was shorter (0.85\u00a0h vs. 1.77\u00a0h; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). ALT was not shorter in patients with positive compared to negative blood cultures (0.63\u00a0h vs. 0.94\u00a0h; <jats:italic>p<\/jats:italic>\u2009=\u20090.053). Antimicrobials ordered in the emergency room had a shorter median ALT than in medical wards (0.43\u00a0h vs. 1.57\u00a0h; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). After correcting for indication, we found no association between ALT and LoS (<jats:italic>p<\/jats:italic>\u2009=\u20090.34).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>ALT is an easily measurable QI for sepsis. More studies are needed to establish whether ALT is a feasible QI for meningitis and community-acquired pneumonia. For all infections, ALT can be used as process indicator for drug administration.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10096-025-05085-w","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T08:04:47Z","timestamp":1741334687000},"page":"1177-1183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The feasibility of antimicrobial lead time as process and quality indicator for hospitals"],"prefix":"10.1007","volume":"44","author":[{"given":"R. I.","family":"Helou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"van der Sijs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rizopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. J.","family":"Verkaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Verbon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"issue":"4","key":"5085_CR1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/CCM.0b013e3181cc4824","volume":"38","author":"DF Gaieski","year":"2010","unstructured":"Gaieski DF, Mikkelsen ME, Band RA, Pines JM, Massone R, Furia FF, Shofer FS, Goyal M (2010) Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 38(4):1045\u20131053","journal-title":"Crit Care Med"},{"issue":"7","key":"5085_CR2","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","volume":"196","author":"VX Liu","year":"2017","unstructured":"Liu VX, Fielding-Singh V, Greene JD, Baker JM, Iwashyna TJ, Bhattacharya J, Escobar GJ (2017) The timing of early antibiotics and hospital mortality in Sepsis. Am J Respir Crit Care Med 196(7):856\u2013863","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"5085_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jemermed.2016.12.009","volume":"53","author":"R Sherwin","year":"2017","unstructured":"Sherwin R, Winters ME, Vilke GM, Wardi G (2017) Does early and appropriate antibiotic administration improve mortality in emergency department patients with severe Sepsis or septic shock?? J Emerg Med 53(4):588\u2013595","journal-title":"J Emerg Med"},{"issue":"6","key":"5085_CR4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.amjms.2018.02.007","volume":"355","author":"RY Kim","year":"2018","unstructured":"Kim RY, Ng AM, Persaud AK, Furmanek SP, Kothari YN, Price JD, Wiemken TL, Saad MA, Guardiola JJ, Cavallazzi RS (2018) Antibiotic timing and outcomes in Sepsis. Am J Med Sci 355(6):524\u2013529","journal-title":"Am J Med Sci"},{"issue":"10","key":"5085_CR5","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1097\/CCM.0000000000003921","volume":"47","author":"MG Kashiouris","year":"2019","unstructured":"Kashiouris MG, Zemore Z, Kimball Z, Stefanou C, Fowler AA 3rd, Fisher B, de Wit M, Pedram S, Sessler CN (2019) Supply chain delays in antimicrobial administration after the initial clinician order and mortality in patients with Sepsis. Crit Care Med 47(10):1388\u20131395","journal-title":"Crit Care Med"},{"issue":"5","key":"5085_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/CCM.0000000000004863","volume":"49","author":"SP Taylor","year":"2021","unstructured":"Taylor SP, Anderson WE, Beam K, Taylor B, Ellerman J, Kowalkowski MA (2021) The association between antibiotic delay intervals and hospital mortality among patients treated in the emergency department for suspected Sepsis. Crit Care Med 49(5):741\u2013747","journal-title":"Crit Care Med"},{"issue":"10","key":"5085_CR7","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1097\/CCM.0000000000003940","volume":"47","author":"M Klompas","year":"2019","unstructured":"Klompas M, Rhee C (2019) Antibiotic Order-to-Infusion time for patients with septic shock: A potential new quality metric. Crit Care Med 47(10):1467\u20131470","journal-title":"Crit Care Med"},{"issue":"6","key":"5085_CR8","doi-asserted-by":"publisher","first-page":"e540","DOI":"10.1097\/CCM.0000000000004292","volume":"48","author":"KA Cawcutt","year":"2020","unstructured":"Cawcutt KA, Beachy M, Peitz GJ (2020) Antibiotic delivery in sepsis: how do we improve?? Crit Care Med 48(6):e540\u2013e541","journal-title":"Crit Care Med"},{"issue":"4","key":"5085_CR9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/cid\/ciaa059","volume":"72","author":"C Rhee","year":"2021","unstructured":"Rhee C, Chiotos K, Cosgrove SE, Heil EL, Kadri SS, Kalil AC, Gilbert DN, Masur H, Septimus EJ, Sweeney DA, Strich JR, Winslow DL, Klompas M (2021) Infectious diseases society of America position paper: recommended revisions to the National severe Sepsis and septic shock early management bundle (SEP-1) Sepsis quality measure. Clin Infect Dis 72(4):541\u2013552","journal-title":"Clin Infect Dis"},{"issue":"11","key":"5085_CR10","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.ijmedinf.2012.07.011","volume":"81","author":"RS Cartmill","year":"2012","unstructured":"Cartmill RS, Walker JM, Blosky MA, Brown RL, Djurkovic S, Dunham DB, Gardill D, Haupt MT, Parry D, Wetterneck TB, Wood KE, Carayon P (2012) Impact of electronic order management on the timeliness of antibiotic administration in critical care patients. Int J Med Inf 81(11):782\u2013791","journal-title":"Int J Med Inf"},{"issue":"7393","key":"5085_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1136\/bmj.326.7393.816","volume":"326","author":"SM Campbell","year":"2003","unstructured":"Campbell SM, Braspenning J, Hutchinson A, Marshall MN (2003) Research methods used in developing and applying quality indicators in primary care. BMJ 326(7393):816\u2013819","journal-title":"BMJ"},{"issue":"2","key":"5085_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cmi.2022.07.007","volume":"29","author":"R Stemkens","year":"2023","unstructured":"Stemkens R, Schouten JA, van Kessel SAM, Akkermans RP, Telgt DSC, Fleuren H, Claassen MAA, Hulscher M, Ten Oever J (2023) How to use quality indicators for antimicrobial stewardship in your hospital: a practical example on outpatient parenteral antimicrobial therapy. Clin Microbiol Infect 29(2):182\u2013187","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"5085_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/MLR.0000000000001222","volume":"58","author":"A Van Wilder","year":"2020","unstructured":"Van Wilder A, Spriet I, Van Eldere J, Peetermans WE, Vanhaecht K, Vandersmissen J, Artois M, Gilis K, Vanautgaerden P, Balcaen K, Rademakers FE, Bruyneel L (2020) Translating data from an electronic prescribing and medicines administration system into knowledge: application to Doctor-Nurse time discrepancy in antibiotic ordering and administration. Med Care 58(1):83\u201389","journal-title":"Med Care"},{"issue":"6","key":"5085_CR14","doi-asserted-by":"publisher","first-page":"e033640","DOI":"10.1136\/bmjopen-2019-033640","volume":"10","author":"RI Helou","year":"2020","unstructured":"Helou RI, Catho G, Peyravi Latif A, Mouton J, Hulscher M, Teerenstra S, Conly J, Huttner BD, Tangden T, Verbon A (2020) Study protocol for an international, multicentre stepped-wedge cluster randomised trial to evaluate the impact of a digital antimicrobial stewardship smartphone application. BMJ Open 10(6):e033640","journal-title":"BMJ Open"},{"issue":"23","key":"5085_CR15","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","volume":"376","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, Lemeshow S, Osborn T, Terry KM, Levy MM (2017) Time to treatment and mortality during mandated emergency care for Sepsis. N Engl J Med 376(23):2235\u20132244","journal-title":"N Engl J Med"},{"issue":"11","key":"5085_CR16","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, McIntyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Moller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47(11):1181\u20131247","journal-title":"Intensive Care Med"},{"issue":"4","key":"5085_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jinf.2016.01.007","volume":"72","author":"F McGill","year":"2016","unstructured":"McGill F, Heyderman RS, Michael BD, Defres S, Beeching NJ, Borrow R, Glennie L, Gaillemin O, Wyncoll D, Kaczmarski E, Nadel S, Thwaites G, Cohen J, Davies NW, Miller A, Rhodes A, Read RC, Solomon T (2016) The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect 72(4):405\u2013438","journal-title":"J Infect"},{"key":"5085_CR18","unstructured":"National Institute for Health and Care Excellence (NICE) (2022) Pneumonia in adults: diagnosis and management - Clinical guideline [CG191]. https:\/\/www.nice.org.uk\/guidance\/cg191. Cited 15-08-2022 2022"},{"issue":"2","key":"5085_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cmi.2020.02.032","volume":"27","author":"P Naucler","year":"2021","unstructured":"Naucler P, Huttner A, van Werkhoven CH, Singer M, Tattevin P, Einav S, Tangden T (2021) Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship. Clin Microbiol Infect 27(2):175\u2013181","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"5085_CR20","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s13054-021-03787-z","volume":"25","author":"MH Kollef","year":"2021","unstructured":"Kollef MH, Shorr AF, Bassetti M, Timsit JF, Micek ST, Michelson AP, Garnacho-Montero J (2021) Timing of antibiotic therapy in the ICU. Crit Care 25(1):360","journal-title":"Crit Care"},{"issue":"8","key":"5085_CR21","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1017\/ice.2018.134","volume":"39","author":"C Rhee","year":"2018","unstructured":"Rhee C, Brown SR, Jones TM, O\u2019Brien C, Pande A, Hamad Y, Bulger AL, Tobin KA, Massaro AF, Anderson DJ, Warren DK, Klompas M, Program CDCPE (2018) Variability in determining sepsis time zero and bundle compliance rates for the centers for medicare and medicaid services SEP-1 measure. Infect Control Hosp Epidemiol 39(8):994\u2013996","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"5085_CR22","first-page":"108","volume":"45","author":"SR Bauer","year":"2019","unstructured":"Bauer SR, Gonet JA, Rosario RF, Griffiths LA, Kingery T, Reddy AJ (2019) Inter-rater agreement for abstraction of the early management bundle, severe sepsis\/septic shock (SEP-1) quality measure in a Multi-Hospital health system. Jt Comm J Qual Patient Saf 45(2):108\u2013111","journal-title":"Jt Comm J Qual Patient Saf"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05085-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05085-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05085-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T12:54:44Z","timestamp":1746708884000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05085-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["5085"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05085-w","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the AB-assistant study was obtained from the institutional review board of the Erasmus MC, Rotterdam, The Netherlands, number MEC-2019-0172.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients included in the study gave their written informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}